Nobiletin improves hyperglycemia and insulin resistance in obese diabetic ob/ob mice

作者：Lee Young Sil; Cha Byung Yoon; Saito Kiyoto; Yamakawa Hiroshi; Choi Sun Sil; Yamaguchi Kohji; Yonezawa Takayuki; Teruya Toshiaki; Nagai Kazuo; Woo Je Tae^*

来源：Biochemical Pharmacology, 2010, 79(11): 1674-1683.

DOI：10.1016/j.bcp.2010.01.034

• Nobiletin
• Homeostasis model assessment index
• Glucose tolerance
• Adipokine
• Glucose transporter

Nobiletin is a polymethoxylated flavone found in certain citrus fruits that exhibits various pharmacological effects including anti-inflammatory, antitumor and neuroprotective properties. The present study investigated the effects of nobiletin on insulin sensitivity in obese diabetic ob/ob mice, and the possible mechanisms involved. The ob/ob mice were treated with nobiletin (200 mg/kg) for 5 weeks. Nobiletin significantly improved the plasma glucose levels, homeostasis model assessment index, glucose tolerance in an oral glucose tolerance test and plasma adiponectin levels. In white adipose tissue (WAT), nobiletin significantly decreased the mRNA expression levels of inflammatory adipokines such as interleukin (IL)-6 and monocyte chemoattractant protein (MCP)-1 and increased the mRNA expression levels of adiponectin, peroxisome proliferator-activated receptor (PPAR)-gamma and its target genes. At the same time, nobiletin increased the glucose transporter (Glut) 4 expression levels in the whole plasma membrane, and Glut1 and phospho-Akt expression in the whole cell lysates in WAT and muscle. Nobiletin also increased Glut4 protein expression level in the whole cell lysates of the muscle. Taken together, the present results suggest that nobiletin improved the hyperglycemia and insulin resistance in obese diabetic ob/ob mice by regulating expression of Glut1 and Glut4 in WAT and muscle, and expression of adipokines in WAT.

• 出版日期2010-6-1